We are analyzing https://link.springer.com/article/10.1007/bf00165391.

Title:
Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain | Naunyn-Schmiedeberg's Archives of Pharmacology
Description:
The effect of long-term oral treatment with caffeine on A1 and A2 receptors in the rat brain was studied. Caffeine was added to the drinking water and the animals were sacrificed after a 12 day treatment period. The plasma caffeine concentration was close to 100 μM. A1 receptors were studied using quantitative autoradiography with [3H]cyclohexyladenosine (CHA). Caffeine treatment increased the number of A1 receptors in the CA3 subfield of the hippocampus from 337 to 393 fmol/mg with no change in KD (0.692 vs. 0.675 nM). A1 mRNA was measured using Northern blots and quantitative in situ hybridization. There was no increase in A1 mRNA. A2a receptors, located in dopamine rich regions of the rat brain, were studied with quantitative autoradiography using [3H]CGS 21680 as the ligand, and the A2a mRNA was determined using quantitative in situ hybridization. Caffeine treatment produced no significant change in either receptor number or mRNA, even though the apparent Bmax tended to increase from 322±8 to 352±8 fmol/mg. The results show that treatment with caffeine in a dose that causes tolerance to several effects of caffeine and increases some effects of adenosine analogues increases the number of A1 receptors without any change in A1 mRNA, suggesting that the adaptive changes are at a post-translational level. There were no significant changes in A2 receptors indicating that the two types are regulated differently and/or that the amount of endogenous agonist is sufficient to regulate A1, but not A2 receptors.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Social Networks

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, adenosine, rat, receptor, receptors, caffeine, brain, treatment, pharmacol, article, mrna, fredholm, effects, dopamine, sci, quantitative, tolerance, theophylline, autoradiographic, res, chronic, privacy, cookies, content, effect, van, longterm, number, hippocampus, increases, access, localization, information, change, publish, search, naunynschmiedebergs, pharmacology, binding, johansson, lindefors, persson, striatum, neuroscience, mol, data, log, journal, research,

Topics {✒️}

g-protein coupled a2-receptors protein-coupled protein month download article/chapter striatal medium-sized neurons long-term oral treatment long-term theophylline treatment long-term caffeine consumption d2 dopamine receptors d1 dopamine receptor adenosine analogues increases privacy choices/manage cookies adenosine a2 receptor vivo pet study long-term treatment van der ploeg adenosine a2 receptors a2-adenosine receptors adenosine a1 receptor a1 adenosine receptor article naunyn-schmiedeberg' full article pdf central nervous system a2 receptors indicating long-term potentiation dopamine rich regions chronic neuroleptic treatment adenosine a1-receptors adenosine a1 receptors nils lindefors & bertil post-translational level chronic theophylline treatment increased receptor number beta receptor number monsma jr fj a2a receptors receptor binding european economic area apparent bmax tended related subjects oligothymidylic acid-cellulose schedule controlled responding vitro hippocampal slice human basal ganglia chain terminating inhibitors caffeine treatment increased caffeine treatment produced ddt1 mf-2 cells cross-tolerance studies drug-specific tolerance rat striatal membranes

Questions {❓}

Fredholm BB (1980) Are methylxanthine effects due to antagonism of endogenous adenosine?
Fredholm BB, Dunwiddie TV (1988) How does adenosine inhibit transmitter release?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain
         description:The effect of long-term oral treatment with caffeine on A1 and A2 receptors in the rat brain was studied. Caffeine was added to the drinking water and the animals were sacrificed after a 12 day treatment period. The plasma caffeine concentration was close to 100 μM. A1 receptors were studied using quantitative autoradiography with [3H]cyclohexyladenosine (CHA). Caffeine treatment increased the number of A1 receptors in the CA3 subfield of the hippocampus from 337 to 393 fmol/mg with no change in KD (0.692 vs. 0.675 nM). A1 mRNA was measured using Northern blots and quantitative in situ hybridization. There was no increase in A1 mRNA. A2a receptors, located in dopamine rich regions of the rat brain, were studied with quantitative autoradiography using [3H]CGS 21680 as the ligand, and the A2a mRNA was determined using quantitative in situ hybridization. Caffeine treatment produced no significant change in either receptor number or mRNA, even though the apparent Bmax tended to increase from 322±8 to 352±8 fmol/mg. The results show that treatment with caffeine in a dose that causes tolerance to several effects of caffeine and increases some effects of adenosine analogues increases the number of A1 receptors without any change in A1 mRNA, suggesting that the adaptive changes are at a post-translational level. There were no significant changes in A2 receptors indicating that the two types are regulated differently and/or that the amount of endogenous agonist is sufficient to regulate A1, but not A2 receptors.
         datePublished:
         dateModified:
         pageStart:407
         pageEnd:414
         sameAs:https://doi.org/10.1007/BF00165391
         keywords:
            Quantitative receptor autoradiography
            In situ hybridization
            Northern blot
            Tolerance
            Hippocampus
            Striatum
            Pharmacology/Toxicology
            Neurosciences
         image:
         isPartOf:
            name:Naunyn-Schmiedeberg's Archives of Pharmacology
            issn:
               1432-1912
               0028-1298
            volumeNumber:347
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Björn Johansson
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Susanne Ahlberg
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ingeborg van der Ploeg
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stefan Brené
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nils Lindefors
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Karolinska Institutet
                     address:
                        name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Håkan Persson
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bertil B. Fredholm
               affiliation:
                     name:Karolinska Institutet
                     address:
                        name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain
      description:The effect of long-term oral treatment with caffeine on A1 and A2 receptors in the rat brain was studied. Caffeine was added to the drinking water and the animals were sacrificed after a 12 day treatment period. The plasma caffeine concentration was close to 100 μM. A1 receptors were studied using quantitative autoradiography with [3H]cyclohexyladenosine (CHA). Caffeine treatment increased the number of A1 receptors in the CA3 subfield of the hippocampus from 337 to 393 fmol/mg with no change in KD (0.692 vs. 0.675 nM). A1 mRNA was measured using Northern blots and quantitative in situ hybridization. There was no increase in A1 mRNA. A2a receptors, located in dopamine rich regions of the rat brain, were studied with quantitative autoradiography using [3H]CGS 21680 as the ligand, and the A2a mRNA was determined using quantitative in situ hybridization. Caffeine treatment produced no significant change in either receptor number or mRNA, even though the apparent Bmax tended to increase from 322±8 to 352±8 fmol/mg. The results show that treatment with caffeine in a dose that causes tolerance to several effects of caffeine and increases some effects of adenosine analogues increases the number of A1 receptors without any change in A1 mRNA, suggesting that the adaptive changes are at a post-translational level. There were no significant changes in A2 receptors indicating that the two types are regulated differently and/or that the amount of endogenous agonist is sufficient to regulate A1, but not A2 receptors.
      datePublished:
      dateModified:
      pageStart:407
      pageEnd:414
      sameAs:https://doi.org/10.1007/BF00165391
      keywords:
         Quantitative receptor autoradiography
         In situ hybridization
         Northern blot
         Tolerance
         Hippocampus
         Striatum
         Pharmacology/Toxicology
         Neurosciences
      image:
      isPartOf:
         name:Naunyn-Schmiedeberg's Archives of Pharmacology
         issn:
            1432-1912
            0028-1298
         volumeNumber:347
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Björn Johansson
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Susanne Ahlberg
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ingeborg van der Ploeg
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stefan Brené
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nils Lindefors
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Karolinska Institutet
                  address:
                     name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Håkan Persson
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bertil B. Fredholm
            affiliation:
                  name:Karolinska Institutet
                  address:
                     name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Naunyn-Schmiedeberg's Archives of Pharmacology
      issn:
         1432-1912
         0028-1298
      volumeNumber:347
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Karolinska Institutet
      address:
         name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
      name:Karolinska Institutet
      address:
         name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Björn Johansson
      affiliation:
            name:Karolinska Institutet
            address:
               name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Susanne Ahlberg
      affiliation:
            name:Karolinska Institutet
            address:
               name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Ingeborg van der Ploeg
      affiliation:
            name:Karolinska Institutet
            address:
               name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Stefan Brené
      affiliation:
            name:Karolinska Institutet
            address:
               name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Nils Lindefors
      affiliation:
            name:Karolinska Institutet
            address:
               name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
            name:Karolinska Institutet
            address:
               name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Håkan Persson
      affiliation:
            name:Karolinska Institutet
            address:
               name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Bertil B. Fredholm
      affiliation:
            name:Karolinska Institutet
            address:
               name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
               type:PostalAddress
            type:Organization
PostalAddress:
      name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
      name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
      name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
      name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
      name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
      name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
      name:The Department of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden
      name:The Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(79)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.51s.

LINK . SPRINGER . COM {}